Literature DB >> 27621899

A case of long-term survival after multimodal local treatments of intramedullary spinal cord metastasis of squamous cell lung cancer.

Shojiro Minomo1, Akihiro Tokoro2, Tomoki Utsumi3, Masahiro Ishihara4, Masanori Akira, Shinji Atagi.   

Abstract

Intramedullary spinal cord metastasis of non-small cell lung cancer is rare, and it has a short prognosis. We report a 53-year-old man diagnosed with cT4N0M0, stage IIIA squamous cell lung cancer. Ten months after left pneumonectomy (pT4N0M0), an intramedullary spinal cord tumor developed at the axis level. The intramedullary spinal cord tumor was resected, and he was diagnosed with metastatic squamous cell lung cancer. Radiotherapies and another tumor resection were conducted, as he had a good performance status and the discrete lesion was associated with the risk of brain stem compression. Multimodal local treatments for intramedullary spinal cord metastasis caused the tumor to shrink, and he lived for 25 months after the spinal metastasis occurred.

Entities:  

Keywords:  Lung neoplasms; multimodal treatment; neoplasm metastasis; spinal cord; squamous cells

Year:  2016        PMID: 27621899      PMCID: PMC4999765          DOI: 10.21037/jtd.2016.06.58

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  12 in total

1.  Leptomeningeal and medullary response to second-line erlotinib in lung adenocarcinoma.

Authors:  Mathilde Wagner; Benjamin Besse; Corinne Balleyguier; Jean-Charles Soria
Journal:  J Thorac Oncol       Date:  2008-06       Impact factor: 15.609

2.  [A case of non-small-cell lung cancer with intramedullary spinal cord metastasis diagnosed pre-mortem].

Authors:  Y Ishibashi; Y Tokuchi; M Kamachi; M Harada; H Isobe
Journal:  Nihon Kokyuki Gakkai Zasshi       Date:  2000-12

3.  Intramedullary spinal cord metastases (ISCM) and non-small cell lung carcinoma (NSCLC): clinical patterns, diagnosis and therapeutic considerations.

Authors:  A Potti; M Abdel-Raheem; R Levitt; D A Schell; S A Mehdi
Journal:  Lung Cancer       Date:  2001 Feb-Mar       Impact factor: 5.705

4.  Clinical outcome in patients with intramedullary spinal cord metastases from lung cancer.

Authors:  C Conill; J Marruecos; E Verger; J Berenguer; F Lomeña; J Domingo-Domènech; J J Grau; F Casas
Journal:  Clin Transl Oncol       Date:  2007-03       Impact factor: 3.405

Review 5.  Intramedullary spinal cord metastases: diagnosis and treatment - an illustrated review.

Authors:  M Kalayci; F Cağavi; S Gül; S Yenidünya; B Açikgöz
Journal:  Acta Neurochir (Wien)       Date:  2004-11-08       Impact factor: 2.216

6.  Clinical features and natural history of intramedullary spinal cord metastasis.

Authors:  J L Grem; J Burgess; D L Trump
Journal:  Cancer       Date:  1985-11-01       Impact factor: 6.860

7.  Complete response of 7 years' duration after chemoradiotherapy followed by gefitinib in a patient with intramedullary spinal cord metastasis from lung adenocarcinoma.

Authors:  Yoshinobu Hata; Yujiro Takai; Hiroshi Takahashi; Keigo Takagi; Kazutoshi Isobe; Chikako Hasegawa; Kazutoshi Shibuya; Hidenori Goto; Kazuyoshi Tamaki; Fumitomo Sato; Hajime Otsuka
Journal:  J Thorac Dis       Date:  2013-04       Impact factor: 2.895

8.  Spinal cord metastasis in small cell carcinoma of the lung.

Authors:  P Holoye; J Libnoch; J Cox; L Kun; R Byhardt; U Almagro; S McClelland; K Chintapali
Journal:  Int J Radiat Oncol Biol Phys       Date:  1984-03       Impact factor: 7.038

9.  Intradural parenchymal involvement in the spinal subarachnoid space associated with primary lung cancer.

Authors:  H Okamoto; T Shinkai; Y Matsuno; N Saijo
Journal:  Cancer       Date:  1993-11-01       Impact factor: 6.860

10.  Retrospective study of 19 patients with intramedullary spinal cord metastasis.

Authors:  Phong Dam-Hieu; Romuald Seizeur; Jean-François Mineo; Jean-Philippe Metges; Philippe Meriot; Hélène Simon
Journal:  Clin Neurol Neurosurg       Date:  2008-10-19       Impact factor: 1.876

View more
  3 in total

1.  Intramedullary Spinal Cord Metastases from Differentiated Thyroid Cancer, a Case Report.

Authors:  Fabio Volpe; Leandra Piscopo; Mariarosaria Manganelli; Maria Falzarano; Federica Volpicelli; Carmela Nappi; Massimo Imbriaco; Alberto Cuocolo; Michele Klain
Journal:  Life (Basel)       Date:  2022-06-09

2.  Successful osimertinib treatment in a patient who exhibited intramedullary spinal cord metastases of lung adenocarcinoma with an acquired EGFR T790M mutation.

Authors:  Kohei Horiuchi; Takanori Asakura; Shinji Sakaguchi; Fumitake Saito
Journal:  BMJ Case Rep       Date:  2019-06-21

3.  Intramedullary spinal cord metastasis in malignancies: an institutional analysis and review.

Authors:  Jincai Lv; Bailong Liu; Xiaoyue Quan; Cheng Li; Lihua Dong; Min Liu
Journal:  Onco Targets Ther       Date:  2019-06-21       Impact factor: 4.147

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.